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SUMMARY
Polymorphisms of interleukin-1b (IL-1b) are associated with an increased risk of solid malignancies. Here, we
show that stomach-specific expression of human IL-1b in transgenic mice leads to spontaneous gastric
inflammation and cancer that correlate with early recruitment of myeloid-derived suppressor cells (MDSCs)
to the stomach. IL-1b activates MDSCs in vitro and in vivo through an IL-1RI/NF-kB pathway. IL-1b trans-
genic mice deficient in T and B lymphocytes develop gastric dysplasia accompanied by a marked increase
in MDSCs in the stomach. Antagonism of IL-1 receptor signaling inhibits the development of gastric preneo-
plasia and suppresses MDSC mobilization. These results demonstrate that pathologic elevation of a single
proinflammatory cytokine may be sufficient to induce neoplasia and provide a direct link between IL-1b,
MDSCs, and carcinogenesis.INTRODUCTION
Many solid malignancies appear to be initiated by tissue injury or
chronic inflammation (Coussens and Werb, 2002). Long-term
use of nonsteroidal anti-inflammatory drugs (NSAIDs) reduces
the risk of many cancers (Baron and Sandler, 2000). Gastric ad-
enocarcinoma is the second most common cancer in the world
and is strongly linked to chronic inflammation (Fox and Wang,
2007). It is now well accepted that infection with a bacterium,
Helicobacter pylori (H. pylori), plays a pivotal role in triggering
the chronic inflammation (gastritis) leading to malignancy (Fox
and Wang, 2007). Chronic inflammation of the stomach initiates
histopathologic progression of chronic gastritis to gastric atro-408 Cancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Incphy, intestinal metaplasia, dysplasia, and finally gastric cancer
(Fox and Wang, 2001). While H. pylori infection is extremely
prevalent, only a small minority (1%) of infected individuals
will, after many years, develop gastric cancer. The variable
response to this common pathogen appears to be governed
by a genetic predisposition for high expression levels of proin-
flammatory cytokines (El-Omar et al., 2001).
A number of clinical studies have suggested that polymor-
phisms in proinflammatory cytokine genes such as IL-1b,
TNF-a, and IL-6 are associated with diverse diseases, including
cancer (Bidwell et al., 1999; Howell et al., 2002). The strongest
association with cancer has been reported for the IL-1b gene
cluster, where polymorphisms of IL-1b have been shown toSIGNIFICANCE
Polymorphisms of proinflammatory cytokines have been associated with increased risk for malignancies. Development of
appropriate proinflammatory cytokine-based cancer models could facilitate the elucidation of molecular mechanisms and
development of therapies. Here, we demonstrate that gastric-specific overexpression of human interleukin-1b (IL-1b) in
transgenic mice is sufficient for stepwise progression of gastric dysplasia and cancer and that activation of NF-kB in
myeloid-derived suppressor cells (MDSCs) is strongly associated with cancer. Blockade by IL-1RA significantly inhibits
histologic progression and reduces MDSC recruitment. Our results suggest that targeted inhibition of IL-1 receptor signal-
ing may be a potential strategy for prevention and treatment of inflammation-dependent cancer. Our data also suggest that
MDSCs contribute not only to cancer progression but also to the earlier stages of carcinogenesis..
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2000; Howell et al., 2003; Wang et al., 2003), particularly gastric
cancer (El-Omar et al., 2001; Figueiredo et al., 2002). IL-1b is
a pleiotropic proinflammatory cytokine that has profound
effects on inflammation and immunity and has been shown to
be induced by H. pylori infection (El-Omar et al., 2001). Carriers
of IL-1b polymorphisms (IL-1b-511T and IL-1b-31C), which
have been linked to enhanced IL-1b production and
increased circulating levels of the cytokine in humans, show an
increased risk of gastric cancer (El-Omar et al., 2001; Fox and
Wang, 2007).
While genetic studies in humans have suggested an important
role for IL-1b in cancer, direct evidence that IL-1b contributes to
Figure 1. IL-1b Transgenic Mice Develop Gastric Inflammation and
Dysplasia/Carcinoma
(A) The construct pBS/H/K-ATPase/b-globin/IL-1b, which contains the mouse
H+/K+-ATPase b subunit gene promoter and the secreted form of hIL-1b
cDNA, was microinjected into fertilized mouse oocytes.
(B) Expression of hIL-1b in the stomachs of 4- and 12-month-old IL-1b
transgenic mice and control mice was determined using a human-specific
IL-1b ELISA kit. Data are the mean ± SD of ten mice.
(C) Expression of human (transgenic) and mouse (endogenous) IL-1b mRNA in
stomach as assessed by RT-PCR.
(D) IL-1b transgenic mice develop gastric hyperplasia (upper lane) and gastritis
(hematoxylin and eosin [H&E] staining, lower lane).
(E) Male line 19 IL-1b transgenic mice develop stomach cancer.
(F) Activation and relocalization of b-catenin in gastric cancer of IL-1b trans-
genic mice. Stomach sections were stained with an anti-b-catenin antibody.
Arrows show nuclear b-catenin-positive cells (brown).Cthe pathogenesis of cancer has been lacking. In addition, the pri-
mary cellular targets of IL-1b’s effects have not been defined.
Studies in mice have suggested that gastric carcinogenesis is
a Th1-mediated disease and that CD4+ T cells are a necessary
component for the induction of atrophic gastritis and preneopla-
sia of the stomach (Roth et al., 1999). Mice deficient in T and B or
only T lymphocytes are resistant to Helicobacter-induced
preneoplasia; however, infusion of CD4+ T cells is able to repro-
duce atrophic gastritis in immunodeficient mice (Eaton et al.,
2001). While IL-1b has direct effects on T lymphocyte function,
recent studies have pointed to myeloid cells as a critical down-
stream target of IL-1b’s actions. IL-1b is known to activate the
NF-kB pathway in myeloid cells through binding to its receptor
IL-1 receptor I (IL-1RI) (Dinarello, 1996). A number of reports
have demonstrated that the transcription factor NF-kB is a key
player linking inflammation and cancer (Karin and Greten, 2005).
Recent studies have indicated a possible role for IL-1b in the
activation of myeloid-derived suppressor cells (MDSCs), also
known as Gr-1+CD11b+ immature myeloid cells, a heteroge-
neous cellular population believed to have immunosuppressive
effects (Dolcetti et al., 2008). While MDSCs are increased in
a number of pathologic conditions (Serafini et al., 2006), they
are significantly overproduced in the bone marrow and spleen
of tumor-bearing mice (Melani et al., 2003; Serafini et al., 2006)
and are elevated in the peripheral blood of cancer patients
(Almand et al., 2001; Young and Lathers, 1999). Accumulating
data have shown that MDSCs infiltrate into tumors and promote
tumor angiogenesis by producing high levels of matrix metallo-
proteinase-9 (MMP9) and by directly incorporating into tumor
endothelium (Ahn and Brown, 2008; Du et al., 2008). MDSCs
have been implicated in tumor refractoriness to anti-VEGF
treatment and likely contribute to TGF-a-mediated metastasis
(Shojaei et al., 2007a; Yang et al., 2008). MDSCs can be mobi-
lized by a variety of tumor-derived factors, including IL-1b, and
can promote tumor progression (Bunt et al., 2006, 2007). Xeno-
graft tumors with IL-1b overexpression show greater accumula-
tion of MDSCs and more rapid tumor progression (Song et al.,
2005), while 4T1 mammary carcinoma tumors implanted into
IL-1R-deficient mice exhibit delayed accumulation of MDSCs
and slower-growing tumors (Bunt et al., 2007).
Thus, while studies in humans and mice have shown a strong
correlation between MDSC infiltration and tumor progression
(Serafini et al., 2006), these models have all been based on
MDSC activation in response to tumor-derived signals. A possi-
ble role for MDSCs in initiating carcinogenesis has not been
studied, and a possible link between IL-1b and MDSCs in models
of chronic inflammation has not been investigated. Therefore, we
generated a transgenic mouse model of gastric-specific over-
expression of human IL-1b (hIL-1b) and investigated the role of
IL-1b in gastric carcinogenesis.
RESULTS
IL-1b Transgenic Mice Develop Spontaneous Gastric
Inflammation and Dysplasia
To investigate a direct pathogenic role of IL-1b in gastric carci-
nogenesis in vivo, we generated an H/K-ATPase/hIL-1b trans-
gene (Figure 1A) that targets constitutively secreted hIL-1b spe-
cifically to parietal cells of the stomach. One high-expressingancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Inc. 409
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42) in the stomach were identified by hIL-1b ELISA (Figure 1B;
see also Figure S1A available online) and mRNA measurements
(Figure 1C; Figure S1B). The levels of IL-6 and TNF-a mRNAs
in the stomach were significantly increased in 4-month-old
transgenic mice compared to wild-type mice. Furthermore, in
a human IL-1b bioassay, serum from transgenic mice could
stimulate (3-fold) secretion of IL-8 from IL-1RI-expressing
HEK293 cells, an effect that could be blocked by IL-1 receptor
agonist (IL-1RA) or an antibody to human IL-1b but not by an
antibody to murine IL-1b (data not shown). Taken together,
these data confirm that the IL-1b transgenic mice express bio-
active human IL-1b.
IL-1b transgenic mice on a C57BL/6J background (five
generations) older than 1 year of age exhibited marked gastric
hyperplasia (Figure 1D, upper lane) and gastritis with inflamma-
tory cell infiltration (Figure 1D, lower lane) compared to age-
matched wild-type (WT) control mice. More than 70% of older
line 19 mice developed severe hyperplasia, chronic inflamma-
tion, parietal cell loss (atrophy), metaplasia, and dysplasia.
Fewer line 42 mice developed atrophy and metaplasia, and
none developed dysplasia (Table S1), consistent with the lower
levels of IL-1b expression in line 42. Overall, inflammation and
histopathologic alteration scores were significantly higher in
IL-1b transgenic mice than in control mice and were signifi-
cantly higher in line 19 mice than in line 42 mice (Table S2).
Mucous metaplasia with expansion of TFF2/SP-expressing
mucous cells, a characteristic premalignant change, was
frequently observed in IL-1b transgenic mice but not control
mice (Figure S1C). Importantly, 30% of male line 19 mice (6 of
20) developed high-grade dysplasia or adenocarcinoma local-
ized to the body of the stomach (Figure 1E; Table S1). The
adenocarcinomas were well differentiated and did not invade
into the submucosa (intramucosal). Immunohistochemical
staining for b-catenin showed nuclear and cytoplasmic locali-
zation of b-catenin in all cases of high-grade gastrointestinal
epithelial neoplasia (GIN)/adenocarcinoma (6 of 6), while cyto-
plasmic and membranous b-catenin staining were observed
in other preneoplastic lesions and only weak membranous
b-catenin staining was observed in normal stomach (Figure 1F).
In addition, nuclear c-Myc staining was also observed in all
cases of GIN/adenocarcinoma, while only rare scattered nu-
clear c-Myc staining was noted in other preneoplastic lesions.
No nuclear c-Myc staining was observed in the foveolar epithe-
lium of normal stomach (Figure S1D). Interestingly, we found
that male IL-1b transgenic mice showed higher levels of IL-6
in both serum and stomach tissues compared to female mice
(Figures S1E and S1F), while there were no differences in the
level of TNF-a between male and female mice (data not shown).
These data indicate that the higher frequency of dysplasia and
cancer in male animals may be associated with a higher level of
IL-6, as reported previously (Naugler et al., 2007). There were
no histological alterations in other organs examined, including
liver, kidney, lung, and heart (data not shown). These results
show that, in the absence of gastric Helicobacter infection,
overexpression of IL-1b can lead to chronic gastritis, metapla-
sia, and high-grade dysplasia/carcinoma, suggesting that
chronic inflammation may be sufficient for cancer initiation
and progression.410 Cancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier IncOverexpression of IL-1b Accelerates the Development
of Gastric Inflammation and Carcinoma in the Setting
of H. felis Infection
Individuals with IL-1b genetic polymorphisms have an
increased risk for gastric cancer, but only in the context of
H. pylori infection (El-Omar et al., 2001). Consistent with these
clinical observations, IL-1b transgenic mice infected with
H. felis developed more severe gastric inflammation and histo-
logic alterations 5 months postinfection (Figure 2A). Scores for
acute and chronic inflammation, hyperplasia, atrophy, and
metaplasia were significantly higher in H. felis-infected IL-1b
transgenic mice compared to infected control mice and
uninfected IL-1b mice (Figure 2B). Levels of TNF-a, IL-6, and
SDF-1a protein were significantly increased in the stomach of
H. felis-infected IL-1b transgenic mice compared to H. felis-
infected control mice and uninfected IL-1b transgenic mice
(Figure 2C and data not shown). Furthermore, all IL-1b mice
(line 42 and line 19) developed varying grades of dysplasia
12 months postinfection, while such lesions were not seen in
H. felis-infected control mice or in uninfected line 42 mice (Fig-
ures 2D and 2E; Table S3). Notably, 8.4% of line 19 (1 of 12) and
10% of line 42 (1 of 10) IL-1b mice with H. felis infection
developed invasive carcinoma. Immunohistochemical staining
showed strong nuclear and cytoplasmic b-catenin and c-Myc
expression in the majority of cells of the invasive gastric can-
cers (Figure 2D). Inflammation, atrophy, and dysplasia scores
were significantly higher in H. felis-infected IL-1b transgenic
mice compared to infected control mice and uninfected
IL-1b mice (Figure 2E; Table S3). These results confirm, in an
in vivo murine model system, earlier clinical observations that
high levels of IL-1b expression increase the risk for gastric can-
cer in the setting of Helicobacter infection (El-Omar et al., 2001;
Figueiredo et al., 2002).
Overexpression of IL-1b in the Stomach Leads
to Mobilization and Recruitment of MDSCs
Next, we investigated the mechanisms involved in IL-1b-induced
inflammation and carcinogenesis. To study a possible role for in-
flammatory cells in this model, we examined the distribution of
lymphoid and myeloid cells in the peripheral blood, spleen, and
stomach at various time points in IL-1b transgenic mice. In
very young (2 months old) mice, which developed only mild gas-
tritis without gastric atrophy (Figure S2A), there was no change in
the frequencies of CD4+CD8+ T cells or CD11b+F4/80+ mono-
cyte/macrophages in IL-1b transgenic mice compared with
age- and gender-matched wild-type mice; however, there was
a significant increase in the frequencies of MDSCs in the periph-
eral blood (Figure 3A; Figure S2B), spleen (Figure 3B;
Figure S2C), and stomach (Figures 3C and 3D) in 2-month-old
IL-1b transgenic mice compared to control mice. The serum
and stomach tissue levels of TNF-a, IL-6, and SDF-1a were sig-
nificantly increased in IL-1b transgenic mice compared to con-
trols (Figure 3E; Figure S2D). Real-time RT-PCR confirmed these
findings (data not shown). The expression of IL-4 and IL-10 in the
stomach was not significantly altered in IL-1b transgenic mice
(data not shown), consistent with a specific effect on proinflam-
matory cytokines. Thus, transgenic overexpression of IL-1b in
the stomach mobilizes MDSC recruitment at the earliest stages.
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cancer.
In 6- and 12-month-old IL-1b transgenic mice, the accumula-
tion of MDSCs in the blood (Figure 3F), stomach (Figure 3G), and
spleen (data not shown) increased steadily and was associated
with development of progressive chronic atrophic gastritis,
a preneoplastic lesion. Consistent with this histopathologic
progression, the numbers of T cells, F4/80+ macrophages,
and p40-Phox+ neutrophils (Figures S3A and S3B) were signifi-
cantly increased in the stomachs of older IL-1b transgenic mice,
although the increases were less than those observed for
MDSCs. There was also a gradual increase in the expression
of inflammatory cytokines, chemokines, and growth factors
(Figure S3C). Furthermore, older IL-1b mice developed spleno-
megaly (Figure S3D) due largely to the accumulation of large
numbers of splenic MDSCs (Figure S3E). Moreover, we found
that male IL-1b transgenic mice exhibited higher levels of
MDSCs in the blood and stomach than female mice
(Figure S3F), which correlated with the higher circulating levels
of IL-6 in male mice compared to female mice (Figures S1E
and S1F). These data suggest that in older IL-1b transgenic
mice, MDSCs continue to accumulate in addition to recruitment
Figure 2. Overexpression of IL-1bAccelerates the De-
velopment of Gastric Inflammation and Carcinoma in
the Setting of H. felis Infection
(A) Stomach sections from line 19 IL-1b transgenic and control
(WT) mice infected with H. felis for 5 months were stained with
H&E.
(B) Pathological scores from stomach of the above mice were
graded according to the diagnostic criteria described in
Experimental Procedures. Data represent the mean ± SD of
16 mice. #p < 0.05 versus WT; *p < 0.01 versus uninfected WT.
(C) Expression of mouse TNF-a and IL-6 in stomach tissue
from mice was determined by ELISA. Data represent the
mean ± SD of six mice. #p < 0.05 versus WT; *p < 0.01 versus
uninfected WT.
(D) IL-1b transgenic mice infected with H. felis for 12 months
developed dysplasia and carcinoma with activation of
b-catenin. The sections from intramucosal/invasive gastric
cancer were stained with anti-b-catenin and anti-c-Myc anti-
bodies. Green arrows indicate invasive gastric cancer; pink ar-
rows show nuclear b-catenin- or c-Myc-positive cells (brown).
(E) Gastric inflammation and pathology scores were graded in
line 19 IL-1b transgenic and control mice infected with H. felis
for 12 months. Data represent the mean ± SD of ten animals.
#p < 0.05 versus WT; *p < 0.01 versus uninfected WT.
of other immune cells and amplification of the in-
flammatory response, resulting in the develop-
ment of gastric neoplasia.
IL-1b Activates MDSCs through an NF-kB
Signal Pathway
A number of previous studies have suggested that
MDSCs are able to suppress the proliferative
response of lymphocytes in tumor-bearing animals
(Song et al., 2005). Our results confirmed that
splenic MDSCs from IL-1b transgenic mice ex-
hibited a strong suppressive effect on CD4+ T cell
proliferation and IFN-g secretion (Figures S4A
and S4B). Next, we investigated whether IL-1b can directly
activate MDSCs. Treatment of bone marrow and splenic
MDSCs from wild-type mice with human IL-1b resulted in a 3- to
4-fold increase in IL-6 and TNF-a mRNA compared to control
MDSCs (Figure S4C). IL-6 protein levels were also significantly
increased in IL-1b-treated MDSCs (Figure S4D). These data
indicate that IL-1b may directly induce IL-6 expression in
MDSCs.
IL-1b has a strong link to NF-kB, a key regulator of cytokine-
dependent inflammatory gene expression (Dinarello, 1996;
Karin and Greten, 2005). To investigate whether IL-1b induces
gene expression in MDSCs by activating the NF-kB signaling
pathway, we sorted bone marrow MDSCs from cis-NF-kBEGFP
transgenic mice, in which enhanced green fluorescent protein
(EGFP) is under the transcriptional control of NF-kB cis-
elements. In these mice, EGFP expression of the cis-NF-kBEGFP
transgene reflects the level of NF-kB activation (Karrasch et al.,
2007; Magness et al., 2004). The purity of sorted MDSCs was
greater than 98% (Figure S4E). Semiquantitative RT-PCR and
real-time RT-PCR showed that IL-1b treatment significantly up-
regulated mRNA expression of EGFP in both EGFP and EGFP+
bone marrow-derived MDSCs from cis-NF-kBEGFP miceCancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Inc. 411
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activates NF-kB in MDSCs. Fluorescence-activated cell sorting
(FACS) analysis of IL-1b-stimulated MDSCs from cis-NF-kBEGFP
mice further confirmed the upregulation of EGFP protein
expression in these cells (Figure 4B), as did antagonism
with the NF-kB inhibitor MG-132, which inhibited IL-1b-
induced EGFP expression in MDSCs (Figure 4A; Figure S4F).
This suggests that IL-1b can activate the NF-kB pathways in
MDSCs.
Although studies have been contradictory as to whether
IL-1RI is expressed in MDSCs (Bunt et al., 2006), we were
able to detect expression of IL-1RI in MDSCs and CD19+ cells
(IL-1RI-positive cells) by FACS using a phycoerythrin (PE)-
tagged IL-1RI antibody (Figure 4C), as well as by RT-PCR
(Figure 4D). Although the density of IL-1RI is known to be quite
low in most cell types, we were able to detect around 2%–6%
IL-1RI+ MDSCs in whole bone marrow MDSCs (data not
shown). Furthermore, we found that IL-1RA, a natural antago-
nist of the IL-1 receptor that binds to IL-1R and thereby inhibits
IL-1b activity (Arend, 2002), blocked IL-1b-induced EGFP
expression (Figure 4A; Figure S4F) and IL-6 production
(Figure 4E) in MDSCs from cis-NF-kBEGFP transgenic mice.
Figure 3. Overexpression of IL-1b in the Stomach
Leads to Mobilization and Recruitment of MDSCs
(A–C) The frequencies of lymphoid and myeloid cells in periph-
eral blood (A), spleen (B), and stomach (C) from 2-month-old
IL-1b mice and age-matched WT mice were measured by
FACS. Data are the mean ± SD of six mice. #p < 0.05, *p < 0.01
versus WT.
(D) Representative FACS blots for detecting lymphoid and
myeloid cells in the stomach of WT and line 19 IL-1b mice.
(E) Expression of mouse TNF-a, IL-6, and SDF-1a in gastric
tissue from 2-month-old mice was determined by ELISA.
Data represent the mean ± SD of six animals. #p < 0.05,
*p < 0.01 versus WT.
(F and G) The kinetics of myeloid-derived suppressor cells
(MDSCs) was determined by FACS in peripheral blood (F)
and stomach (G) of IL-1b and WT mice at different time points.
Data represent the mean ± SD of six animals. #p < 0.05,
*p < 0.01 versus WT.
These data confirm that IL-1b can directly activate
MDSCs through an IL-1b/IL-1RI/NF-kB pathway.
Overexpression of IL-1b Activates NF-kB
in MDSCs In Vivo
To investigate effects of IL-1b overexpression on
NF-kB in vivo, we examined the expression of gas-
tric NF-kB RelA (p65). Strong NF-kB RelA (p65)
staining could be observed in inflammatory cells
in young mice and in occasional dysplastic gastric
glands in older IL-1b mice, compared to rare p65+
cells in the stomachs of control mice (Figure 5A),
suggesting that overexpression of IL-1b may result
in the activation of NF-kB in both inflammatory and
epithelial cells.
To better define the cellular target of IL-1b, as
well as the effects on MDSCs, we next crossed
line 19 IL-1b mice to NF-kBEGFP transgenic mice.
Older (>6 months old) IL-1b;NF-kBEGFP double-transgenic
mice developed spontaneous gastritis and dysplasia (Figure 5B,
left panel). The number of MDSCs was significantly increased in
the blood, spleen, and stomach in 2-month-old IL-1b;NF-kBEGFP
transgenic mice compared withNF-kBEGFP transgenic mice (data
not shown), consistent with previous results (Figures 3A–3C).
Furthermore, the number of EGFP+ MDSCs was also significantly
increased in the blood (Figure 5C; Figure S5A), spleen, and stom-
ach (Figure 5C) in IL-1b;NF-kBEGFP transgenic mice compared
with NF-kBEGFP transgenic mice. Immunofluorescence staining
confirmed that EGFP+ cells in the gastric mucosa were mainly
CD11b+ cells (Figure S5B) and Gr-1+ cells (data not shown). In
older IL-1b;NF-kBEGFP mice, many EGFP+ cells were observed
in the gastric mucosa, whereas fewer EGFP+ cells were observed
in the stomachs of control NF-kBEGFP mice (Figure 5B). The
EGFP+ signal in older (>6 months old) mice was localized primar-
ily to immune cells (Figure 5B, middle and right panels), including
not only MDSCs but also F4/80+ macrophages (Figure S5C),
consistent with late-stage activation of the latter immune
populations.
To determine whether IL-1b modulates NF-kB-dependent
gene expression in MDSCs, we isolated EGFP+ MDSCs from412 Cancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Inc.
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expression by RT-PCR. We found that the mRNA expression
of several NF-kB target genes was significantly increased in
EGFP+ MDSCs isolated from the stomachs of IL-1b transgenic
mice compared to control mice (Figure 5D). These data strongly
suggest that overexpression of IL-1b activates NF-kB in MDSCs
in vivo, resulting in amplification of the proinflammatory
response in a manner that could contribute to the development
of dysplasia.
To further investigate the role of NF-kB signaling in IL-1b-
induced gastric preneoplasia, we treated 3-month-old IL-1b;
NF-kBEGFP mice with the specific NF-kB inhibitor Bay 11-7085
or DMSO (solvent control) for 5 weeks. The number of EGFP+
cells in the stomach was strongly reduced in Bay 11-7085-
treated IL-1b;NF-kBEGFP mice (Figure 5E). FACS analysis
showed that the number of EGFP+ cells in the blood was also sig-
nificantly decreased in Bay 11-7085-treated IL-1b;NF-kBEGFP
mice (Figure S5D). The expression of gastric mouse IL-6, IL-1b,
and TNF-a was significantly decreased in Bay 11-7085-treated
IL-1b;NF-kBEGFP mice (Figure S5E). Moreover, the histopatho-
logic scores were significantly lower in Bay 11-7085-treated
mice than in DMSO-treated mice (Figure 6F). These data demon-
strate that pharmacologic NF-kB inhibition ameliorates IL-1b-
induced gastric inflammation. This suggests the possibility that
MDSCs could be a relevant target, but NF-kB inhibition likely
Figure 4. IL-1b Activates MDSCs through an NF-kB
Signaling Pathway
(A) IL-1b upregulates EGFP mRNA expression by activating
NF-kB in MDSCs. EGFP+ and EGFPMDSCs from NF-kBEGFP
mice were treated with IL-1b in the absence or presence of
50 ng/ml IL-1RA or 1 mM MG-132 for 3 hr. mRNA expression
was determined by real-time PCR. Data are normalized to
untreated EGFP MDSCs and represent the mean ± SD of
four independent experiments.
(B) IL-1b upregulates expression of EGFP protein in MDSCs.
EGFP+ and EGFP MDSCs were treated with IL-1b for 24 hr.
EGFP fluorescence intensities were determined by FACS.
(C) Expression of IL-1RI protein in MDSCs was determined by
FACS using PE-IL-1RI antibody.
(D) IL-1RI mRNA expression in MDSCs as measured by
RT-PCR.
(E) Blocking the IL-1b/NF-kB signaling pathway inhibits IL-1b-
stimulated secretion of IL-6 in MDSCs. EGFP+ MDSCs were
treated with IL-1b in the absence or presence of IL-1RA or
MG-132 for 36 hr. The level of IL-6 was measured by ELISA.
Data represent the mean ± SD of four independent experi-
ments. *p < 0.01 versus IL-1b-treated group.
also affects other cells types, including macro-
phages, granulocytes, and dendritic cells.
IL-1b Induces Gastric Preneoplasia
and Mobilizes MDSCs in the Absence of
Lymphocytes
Previous studies have shown that adaptive im-
mune responses, particularly CD4+ T cells, are
required for the development of Helicobacter-de-
pendent atrophic gastritis and preneoplasia. Both
Rag2/ and T cell-deficient TCRbd/ mice show
no detectable epithelial changes or parietal cell
loss when infected with H. felis or H. pylori (Lee et al., 2007;
Roth et al., 1999). We confirmed that Rag2/ mice did not
develop atrophic gastritis after H. felis infection alone but did
develop atrophy after H. felis infection in combination with a
transfer of splenocytes or CD4+ T cells from wild-type or IL-1b
transgenic mice (data not shown).
Rag2/ mice are deficient in B cells, T cells, and natural killer
(NK) cells but have abundant normal maturation of the myeloid
lineages, including MDSCs (Figures S6A and S6B). Despite the
absence of atrophic gastritis in H. felis-infected Rag2/ mice,
there was a notable increase in the number of myeloid cells
(both MDSCs and monocytes/macrophages) in the stomach
and spleen of infected mice (data not shown).
To investigate the role of MDSCs, independent of lympho-
cytes, in gastric preneoplasia, we crossed line 19 IL-1b trans-
genic mice into a C57BL/6 Rag2/ genetic background to
generate lymphocyte-deficient IL-1b transgenic mice. Unex-
pectedly, IL-1b;Rag2/ mice exhibited spontaneous develop-
ment of atrophic gastritis, metaplasia, and dysplasia (Figures
6A and 6B), accompanied by a marked increase in the number
of MDSCs in the stomach (Figures 6C and 6D), blood (Fig-
ure S6A), and spleen (Figure S6B). These results strongly sug-
gest that atrophic gastritis/dysplasia can occur in the absence
of T cells and that MDSCs may be a critical mediator of early
stages of gastric carcinogenesis.Cancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Inc. 413
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and Suppresses MDSC Mobilization in H. felis-Infected
IL-1b Mce
Next, we sought to investigate whether deficiency of MDSCs or
inhibition of MDSC mobilization and recruitment can suppress
the development of gastritis. Since no MDSC-specific knockout
mice are available at present, we treated 3-month-old IL-1b;
Rag2/ mice with IL-1RA for 6 weeks. Notably, IL-1RA treat-
ment significantly reduced mobilization and recruitment of
MDSCs in the circulation and stomach (Figure 6E) and signifi-
cantly inhibited the development of gastric inflammation and
preneoplasia in IL-1b;Rag2/ mice (Figure 6F).
Since overexpression of IL-1b accelerates the development of
gastric carcinoma in the setting of H. felis infection, we investi-
gated whether suppression of MDSC mobilization and recruit-
ment inhibits the development of gastric inflammation and carci-
noma in H. felis-infected IL-1b mice using IL-1RA. Prophylactic
administration of IL-1RA increased the concentration of IL-1RA
in gastric mucosa (Figure S7A), reduced the mobilization of
circulating MDSCs (Figure 7A) and recruitment of MDSCs in
the stomach of H. felis-infected transgenic and control mice
(Figure S7B), and significantly prevented the development of
Figure 5. Overexpression of IL-1b Activates NF-kB in
MDSCs In Vivo
(A) NF-kB activation in the stomach of IL-1b mice. Sections
were stained with a NF-kB p65 antibody. Arrows indicate
p65+ cells.
(B) Enhanced EGFP expression in IL-1b;NF-kBEGFP mice. Fro-
zen gastric sections from 6-month-old mice of the indicated
genotypes were subjected to H&E staining and double stain-
ing with anti-EGFP (green) and E-cadherin (red) antibodies.
Red staining indicates epithelial cells. Localization of EGFP+
cells is mostly confined to the stromal region.
(C) Increased frequencies of EGFP+ MDSCs in peripheral
blood, spleen, and stomach tissues in IL-1b;NF-kBEGFP mice
as analyzed by FACS. Data represent the mean ± SD of six an-
imals. *p < 0.05 versus NF-kBEGFP.
(D) Increased expression of cytokines in stomach MDSCs
of IL-1b;NF-kBEGFP mice. Stomach MDSCs sorted from
6-month-old NF-kBEGFP and IL-1b;NF-kBEGFP mice were
restimulated with phorbol myristate acetate (PMA) for 4 hr.
mRNA expression was determined by real-time PCR. The data
are normalized to MDSCs of NF-kBEGFP mice and represent
the mean ± SD of three independent experiments. *p < 0.01
versus NF-kBEGFP.
(E) Blocking NF-kB activity by intraperitoneally injecting
Bay 11-7085 prevents EGFP expression in 3-month-old
IL-1b;NF-kBEGFP mice. Representative images were taken
from frozen gastric sections under a fluorescence micro-
scope.
(F) Blocking NF-kB activity inhibits the development of
gastritis. Pathological scores were graded in Bay 11-7085-
or DMSO-treated IL-1b;NF-kBEGFP mice. *p < 0.05 versus
DMSO treatment; n = 8.
inflammation in both transgenic and wild-type
mice infected with H. felis for 5 months (Figure 7B).
IL-1RA treatment significantly reduced the levels of
TNF-a, IL-6, and SDF-1 in the gastric mucosa (Fig-
ures 7C and 7D). Furthermore, IL-1RA treatment
significantly inhibited the development of gastric in-
flammation and improved the histologic scores of other alter-
ations in both transgenic and wild-type mice that were infected
with H. felis for 12 months (Figure 7E). More importantly, none
of the H. felis-infected IL-1b mice developed dysplasia in the
IL-1RA-treated group compared to untreated H. felis-infected
IL-1b mice (Figure 7E). These findings demonstrate that IL-1
receptor blockade can inhibit the development of gastric inflam-
mation and carcinogenesis, which may be due in part to a reduc-
tion of MDSCs in Helicobacter-infected IL-1b mice. Taken
together, the data demonstrate a clear role for IL-1b in the induc-
tion of gastric cancer and implicate MDSCs in promoting
carcinogenesis. However, since neither IL-1RA nor Bay 11-7085
target MDSCs specifically, other downstream targets of IL-1b
might also contribute to gastric neoplasia.
DISCUSSION
In this study, we have established human IL-1b transgenic mice
by targeting expression of hIL-1b to the stomach using the H/K-
ATPase promoter. The IL-1b transgenic mice provide an in vivo
model of inflammation-related cancer that closely mimics devel-
opment of human cancer. Our results indicate that these IL-1b414 Cancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Inc.
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metaplasia, dysplasia, and carcinoma of the stomach and that
IL-1b activation of NF-kB in MDSCs contributes to the develop-
ment of gastric inflammation and initiation of carcinogenesis.
H. felis infection resulted in more rapid progression to gastric
atrophy and cancer in IL-1b transgenic mice. Our current results
provide support and validation for clinical studies that have
suggested a strong link between IL-1b single-nucleotide poly-
morphisms and the risk of gastric cancer in the setting ofH. pylori
infection (El-Omar et al., 2001). In addition, the data offer direct
evidence that elevation of a single proinflammatory cytokines,
IL-1b, is sufficient for the induction of gastric dysplasia/
carcinoma and thus establish a crucial etiological role for IL-1b
in gastric carcinogenesis.
Previous studies have pointed to roles for MDSCs in cancer.
Accumulating data have shown that MDSCs can contribute to
suppression of tumor immunity, resistance to immunotherapy,
tumor angiogenesis, and metastasis (Shojaei et al., 2007b;
Yang et al., 2008). In addition, it has been demonstrated that
overexpression of IL-1b by cancer cells themselves can acceler-
ate tumor progression and its spread in part by mobilization and
recruitment of MDSCs in tumor tissues (Bunt et al., 2006; Song
et al., 2005). Our study suggests for a link between IL-1b and
Figure 6. MDSCs Are Implicated in IL-1b-Induced
Chronic Gastritis and Dysplasia
(A) IL-1b;Rag2/ mice develop spontaneous gastritis and
dysplasia. H&E staining is shown.
(B) Pathological scores were graded in >12-month-old
Rag2/, IL-1b;Rag2/, and IL-1b;Rag2+/+ mice. Data repre-
sent the mean ± SD of ten animals. *p < 0.01 versus Rag2/.
(C and D) Increased number of myeloid cells in the stomach of
6-month-old IL-1b;Rag2/ mice.
(C) Representative FACS blots.
(D) Data in (C) shown as mean cell number per stomach ± SD,
derived from six animals.
(E) IL-1RA treatment inhibits the mobilization and recruitment
of MDSCs in IL-1b;Rag2/ mice. Three-month-old IL-1b;
Rag2/ mice were treated with IL-1RA for 6 weeks. Single-
nucleated cells were isolated, stained with APC-CD11b and
PerCP-Gr-1 antibodies, and analyzed by FACS.
(F) IL-1RA treatment inhibits the development of gastritis in
IL-1b;Rag2/ mice. Pathological scores were graded in IL-
1RA treated and untreated IL-1b;Rag2/ mice. Data repre-
sent the mean ± SD of six animals. *p < 0.05 versus untreated.
MDSCs in carcinogenesis. Several findings in our
study suggest a direct contribution of MDSCs
to IL-1b-induced gastric inflammation and carci-
noma. (1) The mobilization of MDSCs into the
blood, and the recruitment of MDSCs to the stom-
ach, occurred at the very earliest stage of gastric
inflammation in IL-1b transgenic mice. (2) IL-1b
directly activated MDSCs in vivo and in vitro to
induce secretion of proinflammatory cytokines
(IL-6 and TNF-a) and chemokines (SDF-1) in IL-1b
mice at this early stage. (3) IL-1b;Rag2/mice de-
veloped spontaneous gastritis and dysplasia in the
absence of T cells. (4) Antagonism of IL-1 receptor
signaling by IL-1RA inhibited gastric inflammation
and carcinoma and also suppressed MDSC mobilization and re-
cruitment. Interestingly, inhibitory effects of IL-1RA were also
observed in H. felis-infected wild-type mice, suggesting that
the effects were not limited to the transgenic mice. However,
given that MDSCs were not specifically ablated in our model,
a possible role for other cell types (including neutrophils, macro-
phages, dendritic cells, myofibroblasts, endothelial cells, etc.)
cannot be excluded.
One important finding of this study is that IL-1b can directly ac-
tivate MDSCs through an IL-1b/IL-1RI/NF-kB pathway. In prior
studies, such a direct link was not well established, and other
possibilities were considered, including a role for IL-6 in MDSC
activation (Bunt et al., 2006). IL-1R-deficient mice exhibit a de-
layed accumulation of MDSCs, which was partially restored by
IL-6, indicating that IL-6 is a downstream mediator of the IL-1b-
induced expansion of MDSCs (Bunt et al., 2007). However, we
found that while the levels of expression were low in MDSCs,
IL-1RI is clearly expressed in these cells, and IL-1b could directly
activate MDSCs. IL-1b stimulation of MDSCs led to increased
NF-kB activity, both in vitro and in vivo, and increased secretion
of IL-6 and TNF-a. Using an IL-1b;NF-kBEGFP mouse model, we
found that overexpression of IL-1b directly activated NF-kB in
both epithelial cells and immune cells, but the greatest activationCancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Inc. 415
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activation in MDSCs and to the NF-kB downstream target genes
IL-6 and TNF-a.
Activation of the transcription factor NF-kB is a key molecular
link between inflammation and cancer (Karin and Greten, 2005).
Activation of NF-kB occurs downstream of both the Toll-like re-
ceptor (TLR) and IL-1RI pathways through a complex involving
IKKb. We have previously shown that Helicobacter infection
activates the innate immune system through a TLR pathway
(Mandell et al., 2004) leading to induction of NF-kB signaling
and production of cytokines (such as IL-1b, TNF-a, and IL-6)
by macrophages. Knockout of IKKb in myeloid cells has been
Figure 7. IL-1RA Treatment Improves Gastric Pathology and Blocks
MDSC Recruitment in H. felis-Infected IL-1b Mice
(A) IL-1RA treatment inhibits the mobilization of MDSCs. Single-nucleated
cells in peripheral blood were isolated from line 19 IL-1b transgenic and control
mice infected with H. felis for 5 months with or without preventive administra-
tion of IL-1RA. Cells were stained with fluorescence-labeled CD11b and Gr-1
antibodies and analyzed by FACS. *p < 0.05 versus untreated; n = 6.
(B) IL-1RA treatment inhibits the development of gastric inflammation and
preneoplasia in H. felis-infected mice. Histopathological scores in mice are
shown. *p < 0.05 versus untreated; n = 6.
(C and D) Gastric expression of mouse TNF-a and IL-6 (C) and SDF-1a (D) in
the indicated mice was determined by ELISA.
(E) IL-1RA treatment inhibits the development of gastric dysplasia in H. felis-
infected IL-1b mice. Stomach sections from line 19 IL-1b transgenic and WT
mice infected with H. felis for 12 months with or without IL-1RA treatment
for 3 months were graded for histopathologic scores. *p < 0.01 versus
untreated; n = 10.
Error bars indicate ± SD.416 Cancer Cell 14, 408–419, November 4, 2008 ª2008 Elsevier Incshown to downregulate the innate immune system and suppress
both murine hepatocellular and colon carcinoma (Greten et al.,
2004; Maeda et al., 2005; Pikarsky et al., 2004). However, in
these conditional knockouts of IKKb in myeloid cells, the relevant
cell population targeted has not been completely defined,
although IL-6 levels are consistently downregulated in the
knockout animals. In our IL-1b transgenic mice, the levels of
IL-6 and TNF-a were significantly increased in both the stomach
and the serum and correlated well with MDSC mobilization and
recruitment. IL-6 in particular, which is frequently elevated in pa-
tients with cancer, is an important inducer of tumor promotion
and progression and may account for gender differences in
cancer susceptibility (Heikkila et al., 2008; Naugler et al., 2007).
Thus, IL-6 and TNF-a may be major secreted products of
MDSCs and as such serve as direct downstream targets of
IL-1b and NF-kB that amplify the inflammatory immune response
and promote carcinogenesis (Balkwill, 2006; Naugler et al., 2007).
Clinical and epidemiologic studies have suggested a strong
association between chronic inflammation and cancer (Cous-
sens and Werb, 2002). Specific polymorphisms in proinflamma-
tory cytokine genes, such as IL-1b, can now be linked to MDSCs.
Previous studies have demonstrated that MDSCs have immuno-
suppressive properties, and we have confirmed that MDSCs
from our IL-1b mice can inhibit T and B cell proliferation. How-
ever, the development of gastric preneoplasia has in the past
been shown to be related to the host immune response to infec-
tion and largely dependent on CD4+ T cells, which we have again
confirmed in this study. Rag2/ mice were resistant to
Helicobacter-induced gastric atrophy, while Rag2/ mice re-
constituted with whole splenocytes or CD4+ T cells developed
severe atrophic gastritis after H. felis infection. However, IL-1b
transgenic mice showed an early and marked infiltration of the
gastric mucosa with MDSCs at a stage when very few T cells
were present. More importantly, IL-1b mice crossed into a
Rag2/ background (i.e., IL-1b;Rag2/ mice) still spontane-
ously developed gastritis and dysplasia in association with
a marked infiltration of MDSCs, indicating that IL-1b-induced
gastric inflammation may be mediated by MDSCs independently
of a T cell-mediated Th1 immune response. IL-1b is able to
induce gastric atrophy and mobilize MDSCs in lymphocyte-
deficient animals. While the data fall short of demonstrating
that MDSCs are the primary mediator of carcinogenesis in our
model, they do suggest an early role for MDSCs in cancer that
does not dependent on an immunosuppressive role but is
instead more consistent with a proinflammatory role.
In conclusion, our study strengthens the link between IL-1b
and gastric cancer and implicates MDSCs as being important
in the early stages of gastric carcinogenesis. This observation
could lead to a more general understanding of the role of inflam-
mation in carcinogenesis and provides a model for testing the
efficacy of anti-IL-1b therapies in cancer prevention.
EXPERIMENTAL PROCEDURES
Generation of H/K-ATPase hIL-1b Transgenic Mice
and Double-Transgenic Mice
The 1060 bp fragment of the mouse H/K-ATPase b subunit promoter (Lorenz
and Gordon, 1993) and the 550 bp fragment of the mature, secreted form of
human IL-1b cDNA fused with the signal sequence of human IL-1RA (Bjorkdahl
et al., 1999) were subcloned together with a human growth hormone.
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The transgenic construct was used for pronuclear injection of C57BL/6J 3
SJL F2 hybrid zygotes. Potential founders were screened using both PCR
and Southern blot analysis. A high IL-1b-expressing line (line 19) and a lower
IL-1b-expressing line (line 42) were selected and backcrossed to C57BL/6J
mice. The cis-NF-kBEGFP knockin mice (C57BL/6J) were described previously
(Magness et al., 2004). Line 19 IL-1b mice (C57BL/6J) were crossed to
NF-kBEGFP mice to generate IL-1b;NF-kBEGFP (C57BL/6J background). To
generate IL-1b;Rag2/ double-transgenic mice, line 19 IL-1b mice (C57BL/
6J) were crossed to Rag2/ mice (C57BL/6) (Taconic). All animal studies
were performed in Institutional Animal Care and Use Committee (IACUC)-
approved facilities at Columbia University.
H. felis Infection and Drug Treatment
Eight-week-old IL-1b male mice and age-matched C57BL/6J male mice were
infected with H. felis (ATCC strain 49179) by oral gavage with 1 3 108 colony-
forming units every other day three times as described previously (Houghton
et al., 2004). Administration of human IL-1RA or saline by intraperitoneal
(i.p.) injection at a dose of 100 mg/kg/day per mouse began at 3 days after
H. felis infection for prevention and at 5 months after H. felis infection for treat-
ment for 90 days. In a separate experiment, 3-month-old IL-1b;Rag2/ mice
were administered IL-1RA by i.p. injection at a dose of 100 mg/kg/day for
6 weeks. Three-month-old IL-1b;NF-kBEGFP mice were injected i.p. three times
per week with the NF-kB inhibitor Bay 11-7085 (5 mg/kg) (Calbiochem) or
vehicle control (DMSO) for 5 weeks. Animals were euthanatized with CO2,
and serum, stomach, and spleen tissues were collected for further analysis.
Single-Cell Preparation and FACS Analysis
Bone marrow-derived cells (BMDCs) from the femur and tibia of euthanized
mice were flushed and depleted of red blood cells (RBCs) using RBC lysing
buffer (Sigma-Aldrich). Total nucleated cells in peripheral blood were isolated
after erythrocyte lysis. Single splenic cells were obtained by disaggregating
spleen. For single-cell suspension preparation from stomach tissues, the
mucosa of whole stomach was gently scraped free from the serosa; minced;
digested for 1 hr in 1 mM DTT, 1 mM EDTA, 5% FBS in PBS at 37C; filtered
through a 40 mm nylon mesh strainer; and resuspended in Dulbecco’s PBS
(D-PBS) (Houghton et al., 2004). For FACS analysis, single-cell suspensions
were stained with fluorescence-labeled FITC-CD45, PE-CD3, APC-CD19,
PE-Cy7-CD8, Alexa 700-CD4, APC-CD11b, or PerCP-Ly-6G antibodies (BD
Pharmingen) and detected using a LSRII flow cytometer (BD Biosciences).
Data were analyzed using FlowJo7 software (Tree Star).
MDSC Isolation and Treatment
BMDCs from wild-type, IL-1b, and IL-1b;NF-kBEGFP mice were stained with
APC-CD11b and PerCP-Gr-1 antibodies and sorted by BD FACS Aria (BD Bio-
sciences) to obtain CD11b+Gr-1+ MDSCs. MDSCs were cultured in 12-well
plates (Costar) in complete medium (RPMI 1640) supplemented with 10%
FCS. MDSCs were treated with IL-1b in the presence or absence of IL-1RA
or the NF-kB inhibitor MG-132 (Calbiochem) for 3 hr. Cell mRNA was extracted
for RT-PCR. In another experiment, MDSCs were treated with IL-1b in the
presence or absence of IL-1RA or MG-132 for 36 hr. Supernatant (culture
medium) was harvested, and the level of protein in the supernatant was mea-
sured by ELISA.
IL-1RI Assay
IL-1RI expression was detected by FACS. Briefly, 1 3 105 purified MDSCs
from wild-type mouse bone marrow were incubated with 1 mg Fcg III/receptor
(BD Pharmingen) for 30 min at room temperature prior to staining. MDSCs
were incubated with 2 ml PE-labeled IL-1RI antibody or PE-IgG isotype control
(BD Pharmingen) for 45 min at 4C in the dark. Cells were washed twice with
PBS buffer and analyzed by flow cytometry for IL-1RI expression. mRNA
expression of IL-1RI in MDSCs was determined by RT-PCR. Primers used
are listed in Table S4.
Histopathologic Analysis
Stomach and other tissues from transgenic and control mice were fixed in 10%
formalin, embedded in paraffin, cut into 5 mm sections, and stained with hema-
toxylin and eosin. Histopathologic scores in stomach tissues were gradedCaccording to previously described criteria (Fox et al., 2000) by two pathologists
blinded to treatment groups.
Immunohistochemical Staining
Paraffin sections fixed in 10% formalin were incubated with the primary
antibodies rabbit polyclonal TFF2 (Tu et al., 2007); NF-kB p65, F4/80, and
CD11b (Abcam); b-catenin (BD Biosciences); c-Myc (Santa Cruz); and control
IgG2a. Biotinylated secondary antibodies (Jackson ImmunoResearch Labora-
tories, Inc.) and an ABC avidin-biotin-DAB detection kit (Vector Labs) were
used for detection and visualization according to supplied protocols.
Immunofluorescence Staining
Frozen stomach sections (5 mm) were subjected to double-immunofluores-
cence staining by simultaneous incubation of sections with anti-EGFP and
anti-E-cadherin antibodies (Invitrogen) or anti-F4/80 and anti-CD11b anti-
bodies (eBiosciences) overnight and then incubated with FITC-conjugated
anti-rabbit secondary antibody and Texas red-conjugated anti-rat secondary
antibody (Vector Laboratories) for 1 hr at room temperature. Slides were coun-
terstained with 2 mg/ml DAPI (Vector Laboratories). Specimens were observed
with an Olympus FluoView confocal microscope, and images were analyzed
with Adobe Photoshop.
Measurement of Cytokine Levels by ELISA
Levels of human IL-1b and IL-8 and mouse TNF-a, IL-6, IL-1b, SDF-1, IFN-g,
and IL-1RA in supernatant of cultured cells or serum or gastric tissues of trans-
genic mice were determined using an ELISA kit (BD Biosciences). Absorbance
was measured at 450 nm by a Multiscan MC reader, and the samples were
analyzed by Delta Soft II software (BioMetallics, Inc.).
Quantitative and Semiquantitative PCR
Total RNA was isolated from the stomach and spleen of IL-1b mice and
control mice. Reverse transcription was performed using the SuperScript III
First-Strand Synthesis System (Invitrogen), and semiquantitative PCR reac-
tions were performed using a PCR Core Kit (Roche). The resulting PCR
products were analyzed by agarose gel electrophoresis. Quantitative real-
time PCR was performed with a three-step method using an ABI 7300 system
and QuantiTect SYBR Green PCR (QIAGEN). The PCR conditions were as
follows: 95C for 3 min, followed by 40 cycles of 95C for 30 s, 55C for
30 s, and 72C for 30 s. The sequences of primers are listed in Table S4.
Statistics
Data are represented as mean ± SD from at least three independent
experiments or six mice. The significance of the difference between groups
was evaluated by Student’s t test or c2 test. p < 0.05 was considered
significant.
SUPPLEMENTAL DATA
The Supplemental Data include seven figures and four tables and can be found
with this article online at http://www.cancercell.org/supplemental/S1535-
6108(08)00334-6.
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